87 related articles for article (PubMed ID: 2822140)
1. Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cells.
Pols HA; Schilte HP; Visser TJ; Birkenhager JC
Biochim Biophys Acta; 1987 Nov; 931(2):115-9. PubMed ID: 2822140
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.
Pols HA; Birkenhäger JC; Schilte JP; Visser TJ
Biochim Biophys Acta; 1988 Jun; 970(2):122-9. PubMed ID: 2838094
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells.
Petkovich PM; Heersche JN; Tinker DO; Jones G
J Biol Chem; 1984 Jul; 259(13):8274-80. PubMed ID: 6330107
[TBL] [Abstract][Full Text] [Related]
4. Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cells.
Brown AJ; Berkoben M; Ritter CS; Slatopolsky E
Endocrinology; 1992 Jan; 130(1):276-81. PubMed ID: 1309332
[TBL] [Abstract][Full Text] [Related]
5. The effects of MC903 on 1,25-(OH)2D3 receptor binding, 24-hydroxylase activity and in vitro bone resorption.
Pols HA; Birkenhäger JC; Schilte JP; Bos MP; van Leeuwen JP
Bone Miner; 1991 Aug; 14(2):103-11. PubMed ID: 1655130
[TBL] [Abstract][Full Text] [Related]
6. Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells.
Reinhardt TA; Horst RL
Arch Biochem Biophys; 1989 Aug; 272(2):459-65. PubMed ID: 2546501
[TBL] [Abstract][Full Text] [Related]
7. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
8. Heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells.
Pols HA; van Leeuwen JP; Schilte JP; Visser TJ; Birkenhäger JC
Biochem Biophys Res Commun; 1988 Oct; 156(1):588-94. PubMed ID: 2845985
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids increase the 1,25(OH)2D3 receptor concentration in rat osteogenic sarcoma cells.
Manolagas SC; Abare J; Deftos LJ
Calcif Tissue Int; 1984 Mar; 36(2):153-7. PubMed ID: 6331611
[TBL] [Abstract][Full Text] [Related]
10. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells.
Pan LC; Price PA
J Biol Chem; 1987 Apr; 262(10):4670-5. PubMed ID: 3031030
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
13. The effects of sodium butyrate on the retinoic acid-induced changes in 1,25-dihydroxyvitamin D3 receptors in tumorigenic and nontumorigenic bone derived cell lines.
Lee KL; Petkovich PM; Heersche JN
Endocrinology; 1988 Jun; 122(6):2399-406. PubMed ID: 2836162
[TBL] [Abstract][Full Text] [Related]
14. Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
Biochem Biophys Res Commun; 1990 Jun; 169(2):629-35. PubMed ID: 2162670
[TBL] [Abstract][Full Text] [Related]
15. Activation of the 1,25-dihydroxyvitamin D3 receptor in cultured rat osteogenic sarcoma cells.
Werntz DA; Catherwood BD; Deftos LJ; Manolagas SC
J Recept Res; 1985; 5(2-3):147-54. PubMed ID: 2993603
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
17. Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells.
van Leeuwen JP; Pols HA; Schilte JP; Visser TJ; Birkenhäger JC
Calcif Tissue Int; 1991 Jul; 49(1):35-42. PubMed ID: 1654178
[TBL] [Abstract][Full Text] [Related]
18. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
19. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3.
Manolagas SC; Provvedini DM; Murray EJ; Murray SS; Tsonis PA; Spandidos DA
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):856-60. PubMed ID: 3027709
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines.
Masuda S; Kamao M; Schroeder NJ; Makin HL; Jones G; Kremer R; Rhim J; Okano T
Biol Pharm Bull; 2000 Feb; 23(2):133-9. PubMed ID: 10706373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
